Amedisys (AMED) PT Raised to $133 at RBC Capital
Tweet
Share
E-mail
Get Alerts AMED Hot Sheet
Price: $100.99 --0%
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Rating Summary:
6 Buy, 15 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 9 | New: 26
Join SI Premium – FREE
RBC Capital analyst Frank Morgan raised the price target on Amedisys (NASDAQ: AMED) to $133.00 (from $126.00) while maintaining a Outperform rating following solid Q4.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Securitize Corp (SECZ) PT Raised to $12 at StoneX on 'Innovation Exemption'
- RBC Capital Reiterates Sector Perform Rating on Freehold Royalties Ltd. (FRU:CN) (FRHLF)
- Lasertec Corp. (6920:JP) (LSRCF) PT Raised to JPY41,800 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
